Foreword |
|
xi | |
|
|
xiii | |
|
|
|
|
3 | (4) |
|
|
2 Rodents model for toxicity testing and biomarkers |
|
|
7 | (64) |
|
|
3 Minipig models for toxicity testing and biomarkers |
|
|
71 | (22) |
|
|
4 Nonhuman primates in preclinical research |
|
|
93 | (10) |
|
|
|
|
5 Biomarkers of toxicity in zebrafish |
|
|
103 | (10) |
|
|
6 Caenorhabditis elegans as a model for biomarkers of diseases and toxicities |
|
|
113 | (16) |
|
|
|
|
7 Alternative animal toxicity testing and biomarkers |
|
|
129 | (20) |
|
|
|
|
8 Toxicokinetic-toxicodynamic modeling |
|
|
149 | (8) |
|
|
|
Part II Systems Toxicity Biomarkers |
|
|
|
9 Central nervous system toxicity biomarkers |
|
|
157 | (12) |
|
|
|
10 Peripheral nervous system toxicity biomarkers |
|
|
169 | (30) |
|
|
11 Cardiovascular toxicity biomarkers |
|
|
199 | (18) |
|
|
12 Respiratory toxicity biomarkers |
|
|
217 | (24) |
|
|
13 Hepatic toxicity biomarkers |
|
|
241 | (20) |
|
|
|
|
|
14 Conventional and emerging renal biomarkers |
|
|
261 | (8) |
|
|
15 Gastrointestinal toxicity biomarkers |
|
|
269 | (10) |
|
|
16 Biomarkers of acute and chronic pancreatitis |
|
|
279 | (12) |
|
|
17 Skeletal muscle toxicity biomarkers |
|
|
291 | (18) |
|
|
|
|
|
18 Dermal toxicity biomarkers |
|
|
309 | (8) |
|
|
|
|
19 Ocular biomarkers in diseases and toxicities |
|
|
317 | (8) |
|
|
|
|
|
|
20 Biomarkers of toxicity in human placenta |
|
|
325 | (36) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21 Blood and bone marrow toxicity biomarkers |
|
|
361 | (12) |
|
|
22 Immunotoxicity biomarkers |
|
|
373 | (16) |
|
|
Part III Agents Toxicity Biomarkers |
|
|
|
|
389 | (20) |
|
|
|
24 Herbicides and fungicides |
|
|
409 | (24) |
|
|
25 Polychlorinated biphenyls, polybrominated biphenyls, and brominated flame retardants |
|
|
433 | (18) |
|
|
|
26 Polycyclic aromatic hydrocarbons |
|
|
451 | (8) |
|
|
|
|
|
|
|
|
459 | (16) |
|
|
|
475 | (10) |
|
|
|
485 | (36) |
|
|
30 Chemical and biological warfare agents |
|
|
521 | (18) |
|
|
|
31 Freshwater cyanotoxins |
|
|
539 | (10) |
|
|
|
549 | (14) |
|
|
|
33 Poisonous plants: biomarkers for diagnosis |
|
|
563 | (30) |
|
|
|
|
Part IV Pharmaceuticals and Nutraceuticals Biomarkers |
|
|
|
34 Biomarkers of drug toxicity |
|
|
593 | (16) |
|
|
|
|
|
35 Biomarkers of toxicity for dietary ingredients contained in dietary supplements |
|
|
609 | (20) |
|
|
|
36 Nutriphenomics in rodent models: Impact of dietary choices on toxicological biomarkers |
|
|
629 | (18) |
|
|
|
Part V Biomarkers of Petroleum Products and Mixtures Toxicity |
|
|
|
37 Biomarkers of petroleum products toxicity |
|
|
647 | (8) |
|
|
|
38 Biomarkers of chemical mixture toxicity |
|
|
655 | (18) |
|
|
|
|
Part VI Biomarkers of Radiation, Nanoparticles, and Carcinogenesis |
|
|
|
39 Biomarkers of radiation injury and response |
|
|
673 | (16) |
|
|
|
|
|
40 Biomarker analysis for nanotoxicology |
|
|
689 | (8) |
|
|
|
|
41 Engineered nanomaterials: Biomarkers of exposure and effect |
|
|
697 | (20) |
|
|
|
|
|
42 Epigenetic biomarkers in toxicology |
|
|
717 | (12) |
|
|
|
43 Genotoxicity biomarkers: Molecular basis of genetic variability and susceptibility |
|
|
729 | (14) |
|
|
|
|
|
44 Risk factors as biomarkers of susceptibility in breast cancer |
|
|
743 | (16) |
|
|
|
45 Pancreatic and ovarian cancer biomarkers |
|
|
759 | (12) |
|
|
|
46 Prostate cancer biomarkers |
|
|
771 | (14) |
|
|
|
47 Biomonitoring exposures to carcinogens |
|
|
785 | (16) |
|
|
|
|
|
48 Biomarkers of Alzheimer's disease |
|
|
801 | (16) |
|
|
49 Biomarkers of Parkinson's disease |
|
|
817 | (16) |
|
|
|
|
|
50 Cytoskeletal disruption as a biomarker of developmental neurotoxicity |
|
|
833 | (14) |
|
|
|
|
51 Biomarkers of mitochondrial dysfunction and toxicity |
|
|
847 | (16) |
|
|
|
|
|
|
52 Biomarkers of oxidative/nitrosative stress and neurotoxicity |
|
|
863 | (20) |
|
|
|
|
53 Citrulline: Pharmacological perspectives and role as a biomarker in diseases and toxicities |
|
|
883 | (24) |
|
|
|
54 Pathological biomarkers in toxicology |
|
|
907 | (16) |
|
|
|
|
Part VIII Applications of Biomarkers in Toxicology |
|
|
|
55 Biomarkers in drug safety evaluation |
|
|
923 | (24) |
|
|
|
Maria Rosa Martinez-Larranaga |
|
|
56 Membrane transporters and transporter substrates as biomarkers for drug pharmacokinetics, pharmacodynamics, and toxicity/adverse events |
|
|
947 | (18) |
|
|
|
|
57 Biomarkers in biomonitoring of xenobiotics |
|
|
965 | (10) |
|
|
|
|
58 Biomarkers of susceptibility |
|
|
975 | (8) |
|
|
|
|
59 Biomarkers for drugs of abuse and neuropsychiatric disorders: Models and mechanisms |
|
|
983 | (20) |
|
|
|
|
|
60 MicroRNA expression as an indicator of tissue toxicity |
|
|
1003 | (16) |
|
|
|
|
61 Percellome toxicogenomics project as a source of biomarkers of chemical toxicity |
|
|
1019 | (14) |
|
|
62 Transcriptomic biomarkers in safety and risk assessment of chemicals |
|
|
1033 | (6) |
|
|
63 Biomarkers in computational toxicology |
|
|
1039 | (18) |
|
|
|
|
|
|
|
|
|
|
|
64 Biomarkers in toxicology, risk assessment, and environmental chemical regulations |
|
|
1057 | (24) |
|
Index |
|
1081 | |